President Donald Trump Thursday at the White House declared war on America’s tragic opioid abuse problem, calling it a “public health emergency.” He underlined his concern with personal testimony regarding his late brother’s alcohol addiction and pledged that his administration will deal with the issue effectively.

America has a terrible, deep-rooted problem on its hands. Some 59,000 Americans died from it in 2016. More are being lost at the rate of 140 per day. More than 4,000 people in southwestern Pennsylvania have died from it in the past five years.

The monkey is now on Mr. Trump’s back to do what is necessary to attack the problem. His critics have been quick already to assail his Thursday promise, saying that he should have designated it “a national emergency,” a stronger term that could prompt federal funding more rapidly.

It is more appropriate at this point, given the lethal gravity of the problem, to assume that Mr. Trump meant what he said and to determine what he can do now to deal with the crisis, one that can easily touch every American family, regardless of income or social status. A spokesperson of the American Medical Association warmly welcomed the position Mr. Trump took. It will “offer needed flexibility and help direct attention to opioid-ravaged communities,” said Patrice Harris of the AMA’s opioid task force. “There is plenty of work ahead, and the emergency declaration adds further urgency to this epidemic.”

Advertise with us

The first step, unaddressed by Mr. Trump on Thursday, is for Congress to put money behind the campaign. It is a delicate time in government with regard to money, but who would like to argue that other issues, including the activities of U.S. forces in Niger and elsewhere in Africa, should take priority over trying to stop the deaths of Americans from opioids, particularly fentanyl from China and Mexico and the ever-present heroin?

A second step is to have in place a coherent, concrete project for attacking the problem. The White House’s Opioid Commission is expected to present such a plan within the next few days. Congress will then have something to fund, on an urgent basis.

A third step is for Mr. Trump to fill some of the key personnel slots in a national anti-drug program, including a successor to Health and Human Services Secretary Tom Price and a replacement nomination for Rep. Tom Marino as head of the Office of National Drug Control Policy. His nominations to these posts should be of people strong enough to take on America’s pharmaceutical industry, which still sometimes shows itself more interested in profits than in helping produce a healthy America.

A fourth step would be for Mr. Trump to seek repeal of the law passed by the previous Congress and signed by President Barack Obama that hobbles the Drug Enforcement Administration in its efforts to identify and head off the shipments of excessive amounts of opioids and other addictive drugs that are fueling the problem. As of 2015, 2 million Americans were addicted to prescription opioids.

Finally, without getting into the issue of the future or repeal of the Affordable Care Act, the mental health aspect of opioid and other addictions is essential. People know what happens to addicts, but many fall into using drugs anyway. Why? The idea has taken years to receive public acceptance, but the medical profession has come to regard addiction as a disease requiring treatment. Genetic predisposition is a major factor, much in the way that heart disease or other ailments can run in the family. People can make bad decisions with their free will, but usually other behavioral factors are at play. Some of the most troubling stories are about people who fall into addiction after being prescribed pain medication following an injury, who then turn to heroin in lieu of expensive pharmaceuticals.

Mr. Trump’s pledge on Thursday was an important positive first step. We are right to count on him now to follow up.